Participant flow21

How many started, completed or left each group, period by period.

1 to 20 of 21

Period	Milestone	Group	Participants
Overall Study	STARTED	Relapsed Myeloma (<4 Prior Regimens): Low Dose	60
Overall Study	STARTED	Lenalidomide Refractory Myeloma: Low Dose	34
Overall Study	STARTED	Bortezomib/Lenalidomide Refractory/Relapsed Myeloma: Low Dose	35
Overall Study	STARTED	Bortezomib/Lenalidomide Relapsed/Refractory Myeloma: High Dose	35
Overall Study	STARTED	Relapsed Myeloma (< 4 Prior Regimens): High Dose	60
Overall Study	STARTED	Relapsed/Refractory Myeloma: High Dose	120
Overall Study	STARTED	Relapsed Amyloidosis: Low Dose	33
Overall Study	COMPLETED	Relapsed Myeloma (<4 Prior Regimens): Low Dose	39
Overall Study	COMPLETED	Lenalidomide Refractory Myeloma: Low Dose	27
Overall Study	COMPLETED	Bortezomib/Lenalidomide Refractory/Relapsed Myeloma: Low Dose	30
Overall Study	COMPLETED	Bortezomib/Lenalidomide Relapsed/Refractory Myeloma: High Dose	23
Overall Study	COMPLETED	Relapsed Myeloma (< 4 Prior Regimens): High Dose	37
Overall Study	COMPLETED	Relapsed/Refractory Myeloma: High Dose	68
Overall Study	COMPLETED	Relapsed Amyloidosis: Low Dose	9
Overall Study	NOT COMPLETED	Relapsed Myeloma (<4 Prior Regimens): Low Dose	21
Overall Study	NOT COMPLETED	Lenalidomide Refractory Myeloma: Low Dose	7
Overall Study	NOT COMPLETED	Bortezomib/Lenalidomide Refractory/Relapsed Myeloma: Low Dose	5
Overall Study	NOT COMPLETED	Bortezomib/Lenalidomide Relapsed/Refractory Myeloma: High Dose	12
Overall Study	NOT COMPLETED	Relapsed Myeloma (< 4 Prior Regimens): High Dose	23
Overall Study	NOT COMPLETED	Relapsed/Refractory Myeloma: High Dose	52

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00558896/flow